European Union medicine experts on Thursday recommended lifting a temporary EU-wide ban on the sale of a Roche Holding AG anti-HIV drug that had been contaminated with a substance that can be harmful to health.
The European Medicines Agency, or EMEA, said it backed allowing Roche to sell Viracept again because the company had fixed manufacturing problems that saw some batches contaminated with too much ethyl mesilate. The substance can damage DNA and may trigger cancer. read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment